Cargando…
Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study
The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of Helicobacter pylori (Hp) eradication failures. In nearly half of the Cla-resistant Hp infections, Cla-susceptible bacteria are simultaneously present with the Cla-resistant ones (Cla-heteroresistance). The...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275651/ https://www.ncbi.nlm.nih.gov/pubmed/34267605 http://dx.doi.org/10.3389/pore.2021.1609863 |
_version_ | 1783721762400239616 |
---|---|
author | Kim, Jewel Ju Ea Kocsmár, Ildikó Buzás, György Miklós Szirtes, Ildikó Rusz, Orsolya Diczházi, Csaba Szijártó, Attila Hritz, István Schaff, Zsuzsa Kiss, András Kocsmár, Éva Lotz, Gábor |
author_facet | Kim, Jewel Ju Ea Kocsmár, Ildikó Buzás, György Miklós Szirtes, Ildikó Rusz, Orsolya Diczházi, Csaba Szijártó, Attila Hritz, István Schaff, Zsuzsa Kiss, András Kocsmár, Éva Lotz, Gábor |
author_sort | Kim, Jewel Ju Ea |
collection | PubMed |
description | The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of Helicobacter pylori (Hp) eradication failures. In nearly half of the Cla-resistant Hp infections, Cla-susceptible bacteria are simultaneously present with the Cla-resistant ones (Cla-heteroresistance). The proportion of resistant bacteria in the bacterial population (R-fraction) and its predictive role for the use of Cla-based therapies in Cla-heteroresistant infections has not yet been investigated. Our retrospective study analyzed gastric biopsy samples of 62 Hp-positive patients with Cla-heteroresistant infection. Fluorescence In Situ Hybridization technique was used to visualize the coexistence of resistant and susceptible bacteria within one tissue sample. R-fraction was quantified on multichannel microimages by digital morphometry. Resistant bacteria had a patchy distribution within the whole bacterial population causing high diversity among the investigated areas. Patients were subdivided into two major groups according to whether a Cla-based eradication attempt was conducted before or after the biopsy sampling. R-fraction was significantly lower among cases having only one previous Cla-based eradication attempt vs. those that had multiple previous eradications, including at least one Cla-containing therapy (0.41 vs. 0.89, p = 0.0308). Majority of the patients without previous eradication attempt had successful eradication with Cla-containing regimen (59.26%), verified by a negative (13)C-urea breath test or control biopsy. Multivariable model indicated that the therapeutic outcome using Cla-based regimens depended on the bacterial density rather than the R-fraction. Our study raises the potential use of Cla-containing eradication therapies in certain Cla-heteroresistant Hp infections, taking into account the possible predictive role of bacterial density. |
format | Online Article Text |
id | pubmed-8275651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82756512021-07-14 Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study Kim, Jewel Ju Ea Kocsmár, Ildikó Buzás, György Miklós Szirtes, Ildikó Rusz, Orsolya Diczházi, Csaba Szijártó, Attila Hritz, István Schaff, Zsuzsa Kiss, András Kocsmár, Éva Lotz, Gábor Pathol Oncol Res Pathology and Oncology Archive The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of Helicobacter pylori (Hp) eradication failures. In nearly half of the Cla-resistant Hp infections, Cla-susceptible bacteria are simultaneously present with the Cla-resistant ones (Cla-heteroresistance). The proportion of resistant bacteria in the bacterial population (R-fraction) and its predictive role for the use of Cla-based therapies in Cla-heteroresistant infections has not yet been investigated. Our retrospective study analyzed gastric biopsy samples of 62 Hp-positive patients with Cla-heteroresistant infection. Fluorescence In Situ Hybridization technique was used to visualize the coexistence of resistant and susceptible bacteria within one tissue sample. R-fraction was quantified on multichannel microimages by digital morphometry. Resistant bacteria had a patchy distribution within the whole bacterial population causing high diversity among the investigated areas. Patients were subdivided into two major groups according to whether a Cla-based eradication attempt was conducted before or after the biopsy sampling. R-fraction was significantly lower among cases having only one previous Cla-based eradication attempt vs. those that had multiple previous eradications, including at least one Cla-containing therapy (0.41 vs. 0.89, p = 0.0308). Majority of the patients without previous eradication attempt had successful eradication with Cla-containing regimen (59.26%), verified by a negative (13)C-urea breath test or control biopsy. Multivariable model indicated that the therapeutic outcome using Cla-based regimens depended on the bacterial density rather than the R-fraction. Our study raises the potential use of Cla-containing eradication therapies in certain Cla-heteroresistant Hp infections, taking into account the possible predictive role of bacterial density. Frontiers Media S.A. 2021-06-29 /pmc/articles/PMC8275651/ /pubmed/34267605 http://dx.doi.org/10.3389/pore.2021.1609863 Text en Copyright © 2021 Kim, Kocsmár, Buzás, Szirtes, Rusz, Diczházi, Szijártó, Hritz, Schaff, Kiss, Kocsmár and Lotz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pathology and Oncology Archive Kim, Jewel Ju Ea Kocsmár, Ildikó Buzás, György Miklós Szirtes, Ildikó Rusz, Orsolya Diczházi, Csaba Szijártó, Attila Hritz, István Schaff, Zsuzsa Kiss, András Kocsmár, Éva Lotz, Gábor Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study |
title | Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study |
title_full | Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study |
title_fullStr | Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study |
title_full_unstemmed | Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study |
title_short | Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant Helicobacter pylori Infections: An In Situ Detected Susceptibility and Quantitative Morphometry-Based Retrospective Study |
title_sort | efficacy of clarithromycin depends on the bacterial density in clarithromycin-heteroresistant helicobacter pylori infections: an in situ detected susceptibility and quantitative morphometry-based retrospective study |
topic | Pathology and Oncology Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275651/ https://www.ncbi.nlm.nih.gov/pubmed/34267605 http://dx.doi.org/10.3389/pore.2021.1609863 |
work_keys_str_mv | AT kimjeweljuea efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT kocsmarildiko efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT buzasgyorgymiklos efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT szirtesildiko efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT ruszorsolya efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT diczhazicsaba efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT szijartoattila efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT hritzistvan efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT schaffzsuzsa efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT kissandras efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT kocsmareva efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy AT lotzgabor efficacyofclarithromycindependsonthebacterialdensityinclarithromycinheteroresistanthelicobacterpyloriinfectionsaninsitudetectedsusceptibilityandquantitativemorphometrybasedretrospectivestudy |